Skip to main content
TipRanks
Go Ultimate75% OFF

Seelos Therapeutics (SEELQ) Stock Statistics & Valuation Metrics

1,198 Followers

Total Valuation

Seelos Therapeutics has a market cap or net worth of $1.00. The enterprise value is $11.36T.

Market Cap
$1.00
Enterprise Value
$11.36T

Share Statistics

Seelos Therapeutics has 1,362,880 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,362,880
Owned by Insiders
―
Owned by Institutions
2.36%

Financial Efficiency

Seelos Therapeutics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
-464.56K
Employee Count
16
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Seelos Therapeutics had revenue of ― and earned -7.43M in profits. Earnings per share was ―.

Revenue
―
Gross Profit
1.87M
Operating Income
-13.66M
Pretax Income
―
Net Income
-7.43M
EBITDA
-6.57M
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
-25.17
52-Week Price Change
0.00%
50-Day Moving Average
0.18
200-Day Moving Average
0.18
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Seelos Therapeutics upcoming earnings date is ―, TBA (Not Confirmed).

Last Earnings Date
Apr 25, 2025
Next Earnings Date
―
Ex-Dividend Date
―

Balance Sheet

Seelos Therapeutics has ― in cash and marketable securities with $147.00K in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
$147.00K
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Scores

Smart Score
―
AI Score
30